{"name":"Complexa, Inc.","slug":"complexa-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CXA-10 emulsion","genericName":"CXA-10 emulsion","slug":"cxa-10-emulsion","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CXA-10 emulsion","genericName":"CXA-10 emulsion","slug":"cxa-10-emulsion","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQdVRKRUozaGxXdnVsQWx2SFE0bFlhaktSRHd2Ny1jOTF4X01ZV0tmVHFKRVA3QmVWSW51LWZjLWQyV2lyNk50UFBuLVoxOUhFSTNvT1RQZ1NWQW9uemVKaDBGZlN3TGNiYVNEZEtzcC0tb2FaREx6Ui1ibzNaX0x6cjJySmRNVkU2cTR3MkNVZzVaZkhy?oc=5","date":"2021-05-06","type":"pipeline","source":"SynBioBeta","summary":"Azitra Appoints Francisco Salva as Chief Executive Officer - SynBioBeta","headline":"Azitra Appoints Francisco Salva as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPYU91b18yVzhpWVBkTzhsRmdUT0xPbHZrcUt6UVJGeENCLUZDMGFVbjdxQnptdWY4SGhuWGk1OTRCRnYtRVVSczBVRjQzVDBrbzNjZ2dnNi1aMWdGZU44NjlGTU1jeVoxWTVBdXZodF9ib0lyTHZiR2xYSktrdmR3akY2NnF1b29sTzhfaUt5NEdkeWgyQW1lZWZGTDdMT056NDZkc1RxcEpuM0NGZFN2VG1rcjJBdG8?oc=5","date":"2017-08-09","type":"pipeline","source":"Inquirer.com","summary":"An $872 million week for Philly biotech companies - Inquirer.com","headline":"An $872 million week for Philly biotech companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOdDF6WkszOHBxZ1Mybk50SHA0NVdaQWtiR0xRNkhHOWJjZlZVQ3QwdEd3UlVsVFppSEtnQzRpUFdER3MtekMyUXc2clBrN3NUOWtscUpLSm9mSG0ySjU4ekNPNGN4dHhwR3VtN2kxZlpsM2c2ZDRWUFJCRjB2WVg5V2s5NkxWTzhZUlBaUWpnT3ZMZVRmYzI0RHFtMy1WNnVLcng4QXNvNC03c3dpN1BqOElCNlBqQjhJa3VnTHZHMlVzcmIwTG03QUgwTmVGRjJjcmstNVFIMTR2bUJucllnMDB4cXg4c0NqUElBbUU4c2V6SU45N0ZiRw?oc=5","date":"2017-07-26","type":"trial","source":"PR Newswire","summary":"Complexa Raises $62 Million in Series C Financing to Test CXA-10 in Two Orphan Disease Proof-of-Concept Trials - PR Newswire","headline":"Complexa Raises $62 Million in Series C Financing to Test CXA-10 in Two Orphan Disease Proof-of-Concept Trials","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}